Clovis Oncology, Inc. Assets, Fair Value Disclosure
Clovis Oncology, Inc. had Assets, Fair Value Disclosure of $390.22 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2019-02-28
- 2018-12-31: Assets, Fair Value Disclosure $390.22M.
- 2017-12-31: Assets, Fair Value Disclosure $532.67M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2018-12-31 | $390.22M 10-K · filed 2019-02-28 |
| 2017-12-31 | $532.67M 10-K · filed 2019-02-28 |